NCT01094860
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +39 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Leukemia, Prolymphocytic
Explore clinical trials studying Leukemia, Prolymphocytic. Study availability and eligibility vary by location and protocol.
27 public trials
10 recruiting studies
Leukemia, Prolymphocytic trial results
- Conditions
- B-Cell Prolymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +51 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
- Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States
Completed
Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD)
NCT00124189
- Conditions
- Chronic Disease, Chronic Lymphoproliferative Diseases, Disease Attributes, +17 more
- Locations
-
- Rocky Mountain Cancer Center Denver, Colorado, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- Roswell Park Cancer Center Buffalo, New York, United States
- Long Island Jewish Medical Center New Hyde Park, New York, United States
NCT00749502
- Conditions
- Adnexal Diseases, Chronic Disease, Chronic Lymphocytic Leukemia, +38 more
- Locations
-
Not specified
Active, Not Recruiting
Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin Lymphoma
NCT03479268
- Conditions
- B-Cell Prolymphocytic Leukemia, Chronic Disease, Disease Attributes, +40 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
Active, Not Recruiting
Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia
NCT02153580
- Conditions
- B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma, B-Cell Prolymphocytic Leukemia, Burkitt Lymphoma, +43 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
Active, Not Recruiting
Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients
NCT05823571
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, CML, +34 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States